More news
- Analysis: U.S. healthcare stocks face obstacles after 2011 run
- These Dividend-Paying, 'Recession-Proof,' 'Bond Substitute' Stocks Are Underperforming
- 5 Pharmaceutical Stocks To Consider Now
- Cramer Lightning Round - People's United Financial Is Like Watching Paint Dry (2/8/12)
- Beating The Market Is Harder Than You Think
- Bayer expects China approval for stroke drug Xarelto
- Bayer expects China approval for stroke drug Xarelto
- Watson CEO Seeks ‘Transformational’ Deal in Brand-Name Drugs
- Modified Study, Same Bloody Results
- Final Glance: Pharmaceuticals companies
- Hit The Refresh Button
- Oakmark's Nygren: BAC On Right Course; Favors MRK, BMY Vs. JNJ
